97313223 - ENDO GENERICS PAR PHARMACEUTICAL

Information

  • Trademark
  • 97313223
  • Serial Number
    97313223
  • Registration Number
    7052815
  • Filing Date
    March 15, 2022
    4 years ago
  • Registration Date
    May 16, 2023
    3 years ago
  • Transaction Date
    May 02, 2024
    2 years ago
  • Status Date
    May 16, 2023
    3 years ago
  • Published for Opposition Date
    February 28, 2023
    3 years ago
  • Location Date
    May 16, 2023
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BAGLINI, KAREN
  • Attorney Docket Number
    ENDO1405US
    Attorney Name
    Camille M. Miller
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
3
Mark Identification
ENDO GENERICS PAR PHARMACEUTICAL
Case File Statements
  • GS0411: Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations and medicines, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies
  • GS0401: Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
  • DM0000: The mark consists of a hexagon shape on an angle with intermittent solid vertical lines, with the words "ENDO GENERICS" in lower case font to the right and the words "PAR PHARMACEUTICAL" in title case font underneath.
  • GS0051: Pharmaceutical and medical preparations and ready-to-administer injectable pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, and for the treatment of pain, allergic reactions, hypotension, shock, malignant diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating the skin, and to provide and reverse muscle relaxation, all to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; Pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of asymmetries and defects in conditions of the human skin; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and creams for dermatological use; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine
  • DS0000: "GENERICS" AND "PHARMACEUTICAL"
  • GS0101: Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devices, namely, surgical equipment in the fields of urology and men's health; Medical devices, namely, intrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine
  • GS0421: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others
Case File Event Statements
  • 3/21/2022 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/18/2022 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/22/2022 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/10/2022 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/16/2022 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/16/2022 - 4 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/16/2022 - 4 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/2/2022 - 3 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/2/2022 - 3 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/2/2022 - 3 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/23/2022 - 3 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/23/2022 - 3 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 8/23/2022 - 3 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 11/18/2022 - 3 years ago
    14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/19/2023 - 3 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 1/20/2023 - 3 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/20/2023 - 3 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/23/2023 - 3 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/8/2023 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/28/2023 - 3 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/28/2023 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/16/2023 - 3 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/16/2023 - 3 years ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/1/2024 - 2 years ago
    24 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN